Perampanel

CHEMBL1214124 Phase 4 Approved Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

349.4 g/mol

LogP

3.4

Phase

4

This anti-seizure medication treats epilepsy by blocking brain receptors that trigger seizure activity.

Molecular Weight

349.4000 g/mol

LogP

3.40

TPSA

57.00 Å²

Lipinski RO5

Pass

Therapeutic Areas

Bipolar Disorder Epilepsy Major Depressive Disorder Migraine Parkinson's Disease Stroke

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Structure

SVG PNG

Cite this structure

Embed this structure

SMILES

N#Cc1ccccc1-c1cc(-c2ccccn2)cn(-c2ccccc2)c1=O

InChI

InChI=1S/C23H15N3O/c24-15-17-8-4-5-11-20(17)21-14-18(22-12-6-7-13-25-22)16-26(23(21)27)19-9-2-1-3-10-19/h1-14,16H

Molecular Formula

C23H15N3O

HBD / HBA

- / 3

Rotatable Bonds

3

Heavy Atoms

27

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Frequently Asked Questions

This anti-seizure medication treats epilepsy by blocking brain receptors that trigger seizure activity.

Yes, Perampanel is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1214124. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 9924495. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Looking for patient-friendly information?

Perampanel on PillFYI

Structure

Quick Data

Formula: C23H15N3O
Synonyms: 1

External Links

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Medical Disclaimer

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.